Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 41: 713-716, 1995;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weykamp, C. W.
Right arrow Articles by van der Slik, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weykamp, C. W.
Right arrow Articles by van der Slik, W.

Clinical Chemistry, Vol 41, 713-716, Copyright © 1995 by American Association for Clinical Chemistry

Vitamin C and glycohemoglobin

CW Weykamp, TJ Penders, H Baadenhuijsen, FA Muskiet, W Martina and W van der Slik
Department of Clinical Chemistry, Queen Beatrix Hospital, Winterswijk, The Netherlands.

Three groups of 10 age- and sex-matched nondiabetic volunteers took 0, 750, or 1500 mg of vitamin C each day for 12 weeks. Glycohemoglobin (GHb) was measured by HPLC, electrophoresis, affinity chromatography, and immunoassay at baseline (-4 weeks and -1 day), during supplementation (6 weeks and 12 weeks), and after supplementation ended (6 and 12 weeks). Plasma vitamin C increased twofold during supplementation but, in contrast with the results of Davie et al. (Diabetes 1992; 41:167-73), there were no between-group differences in GHb, glucose, and fructosamine concentrations. Fructosamine may have increased with storage time. The net effects of vitamin C on absolute GHb at 12 weeks vs -1 day (and at 12 weeks vs 12 weeks after) in % GHb amounted to: HPLC -0.035 (-0.050); electrophoresis +0.005 (+0.035); affinity chromatography -0.070 (+0.015); and immunoassay -0.110 (+0.025). We conclude that supplementation of nondiabetics with 750 or 1500 mg of vitamin C daily for 12 weeks does not cause interference in GHb determinations by HPLC, electrophoresis, affinity chromatography, or immunoassay, and does not reduce in vivo Hb glycation.


The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
C. A. Krone and J. T.A. Ely
Vitamin C and Glycohemoglobin Revisited
Clin. Chem., January 1, 2001; 47(1): 148 - 148.
[Full Text] [PDF]

Home page
 Fam PractHome page
C.-S. Liu, C.-C. Lin, H.-C. Shih, and T.-C. Li
The advisability of implementing cholesterol screening in school-age children and adolescents with a family history of cardiovascular disease and hyperlipidaemia
Fam. Pract., October 1, 1999; 16(5): 501 - 505.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Coll. Nutr.Home page
J. J. Cunningham
The Glucose/Insulin System and Vitamin C: Implications in Insulin-Dependent Diabetes Mellitus
J. Am. Coll. Nutr., April 1, 1998; 17(2): 105 - 108.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Association for Clinical Chemistry.